1.
Gleixner KV, Peter B, Blatt K, Suppan V, Reiter A, Radia D, Hadzijusufovic E, Valent P. Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V. Haematologica [Internet]. 2013Sep.4 [cited 2026Nov.1];98(9):1450-7. Available from: https://haematologica.org/article/view/6780